The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Mesorectal excision for rectal cancer
Abstract
Concern about world wide local recurrence rates for rectal cancer of 20-45%, together with anxiety at the recent proliferation of adjuvant therapies, led us to review the efficacy of total mesorectal excision (TME) with which no adjuvant therapy had been combined. Precise, sharp dissection is undertaken around the integral mesentery of the hind gut, which envelopes the entire mid rectum. This procedure adds to operative time and complications but has been claimed to eliminate virtually all locally recurrent disease after "curative" surgery. Independent analysis (J. K. M.) of prospective follow-up data extended over a 13-year interval (1978-91; mean 7.5 years). The actuarial local recurrence rate after curative anterior resection at 5 years is 4% (95% Cl 0-7.5%) and the overall recurrence rate is 18% (10-25%). 10-year figures are 4% (0-11%) and 19% (7-32%). In view of the high-risk classification used for the North Central Cancer Treatment Group (NCCTG), which has led to a trend to chemoradiotherapy, a similar group of high-risk Basingstoke cases was constructed for comparison purposes. This group included 135 consecutive Dukes' B (B2) and Dukes' C cancer operations, both anterior resection and abdominal-perineal excision, for tumours below 12 cm from the anal verge. Results from TME alone are substantially superior to the best reported (NCCTG) from conventional surgery plus radiotherapy or combination chemoradiotherapy: 5% local recurrence at 5 years compared with 25% and 13.…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The mesorectum in rectal cancer surgery—the clue to pelvic recurrence?
Heald, R. J., Husband, E. M., & Ryall, R. D. H. (1982) · Journal of British Surgery · doi:10.1002/bjs.1800691019 · Cited by 2,917
Self-citationRECURRENCE AND SURVIVAL AFTER TOTAL MESORECTAL EXCISION FOR RECTAL CANCER
Heald, R. J., & Ryall, R. D. H. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91510-2 · Cited by 2,710
Self-citationLevamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., Laurie, J. A., Goodman, P. J., Ungerleider, J. S., Emerson, W. A., Tormey, D. C., Glick, J. H., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002083220602 · Cited by 2,256
Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma
Krook, J. E., Moertel, C. G., Gunderson, L. L., Wieand, H. S., Collins, R. T., Beart, R. W., Kubista, T. P., Poon, M. A., Meyers, W. C., Mailliard, J. A., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103143241101 · Cited by 1,879
Prolongation of the Disease-Free Interval in Surgically Treated Rectal Carcinoma
Gastrointestinal Tumor Study Group (1985) · New England Journal of Medicine · doi:10.1056/nejm198506063122301 · Cited by 1,130
Adjuvant Therapy for Patients With Colon and Rectal Cancer
(1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450110090034 · Cited by 1,086
Fisher, B., Wolmark, N., Rockette, H., Redmond, C., Deutsch, M., Wickerham, D. L., Fisher, E. R., Caplan, R., Jones, J., Lerner, H., et al. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.1.21 · Cited by 1,030
The ‘Holy Plane’ of Rectal Surgery
Heald, R. J. (1988) · Journal of the Royal Society of Medicine · doi:10.1177/014107688808100904 · Cited by 804
Self-citationGÉRARD, A., BUYSE, M., NORDLINGER, B., LOYGUE, J., PÈNE, F., KEMPF, P., BOSSET, J.-F., GIGNOUX, M., ARNAUD, J.-P., DESAIVE, C., et al. (1988) · Annals of Surgery · doi:10.1097/00000658-198811000-00011 · Cited by 665
Patterns of recurrence after curative resection of carcinoma of the colon and rectum.
Galandiuk, S., Wieand, H. S., Cg, M., Cha, S. S., Rj, F., Jh, P., & Wolff, B. G. (1992) · PubMed · Cited by 438
Cited by
Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer
Kapiteijn, E., Marijnen, C. A. M., Nagtegaal, I. D., Putter, H., Steup, W. H., Wiggers, T., Rutten, H. J. T., Pahlman, L., Glimelius, B., van Krieken, J. H. J. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010580 · Cited by 4,205
Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer
(1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361402 · Cited by 2,517
Japanese Society for Cancer of the Colon and Rectum, Watanabe, T., Muro, K., Ajioka, Y., Hashiguchi, Y., Ito, Y., Saito, Y., Hamaguchi, T., Ishida, H., Ishiguro, M., et al. (2018) · International Journal of Clinical Oncology · doi:10.1007/s10147-017-1101-6 · Cited by 2,467
Hashiguchi, Y., Muro, K., Saito, Y., Ito, Y., Ajioka, Y., Hamaguchi, T., Hasegawa, K., Hotta, K., Ishida, H., Ishiguro, M., et al. (2020) · International Journal of Clinical Oncology · doi:10.1007/s10147-019-01485-z · Cited by 1,922
Habr-Gama, A., Perez, R. O., Nadalin, W., Sabbaga, J., Ribeiro, U., Silva e Sousa, A. H., Campos, F. G., Kiss, D. R., & Gama-Rodrigues, J. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000141194.27992.32 · Cited by 1,893
Metadata
- Authors
- MacFarlane, J. K., Ryall, R. D. H., & Heald, R. J.
- Affiliations
- University of British Columbia (CA)
- Basingstoke and North Hampshire Hospital (GB)
- ORCID
- Heald, R.J.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1993-02
- Volume
- 341
- Issue
- 8843
- Pages
- 457-460
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2107371365
- Cited by
- 1,781
- References
- 14
- Citations by year
- 2026: 20 · 2025: 24 · 2024: 21 · 2023: 32 · 2022: 41 · 2021: 42 · 2020: 71 · 2019: 61 · 2018: 50 · 2017: 51 · 2016: 60 · 2015: 61 · 2014: 70 · 2013: 63 · 2012: 59
- FWCI
- 12.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Health Sciences › Medicine › Surgery › Colorectal and Anal Carcinomas
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Keywords
- total mesorectal excision, rectal cancer, local recurrence, adjuvant therapy, anterior resection, high-risk classification, chemoradiotherapy, surgical outcomes
- MeSH terms
- Aged, Humans, Methods, Neoplasm Recurrence, Local, Rectal Neoplasms, Risk Factors, Life Tables
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mesorectal excision for rectal cancer. https://app.cochat.ai/papers/10.1016/0140-6736(93)90207-w
- The paper
- MacFarlane, J. K., Ryall, R. D. H., & Heald, R. J. (1993). Mesorectal excision for rectal cancer. The Lancet. https://doi.org/10.1016/0140-6736(93)90207-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.